Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes

Published:2006-12 Issue:4_suppl Volume:13 Page:4-11
ISSN:1073-2748
Container-title:Cancer Control
language:en
Short-container-title:Cancer Control

Author:

List Alan F.¹,Baker Amanda F.²,Green Sylvan³,Bellamy William⁴

Affiliation:

1. Malignant Hematology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

2. Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona

3. Mel and Enid Zuckerman Arizona College of Public Health, Tucson, Arizona

4. Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107327480601304s02

Reference15 articles.

1. Biological and Prognostic Significance of Chromosome 5q Deletions in Myeloid Malignancies

2. Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

3. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

4. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

5. Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications;European Journal of Haematology;2024-01-31

2. In the Pipeline: Emerging Therapy for MDS and MDS/MPN;Pathogenesis and Treatment of Leukemia;2023

3. Current Management and New Developments in the Treatment of Myelodysplastic Syndrome;Cancer Treatment and Research;2021

4. Effect of Cosolvents on the Solubility of Lenalidomide and Thermodynamic Model Correlation of Data;Journal of Chemical & Engineering Data;2019-09-10

5. Lenalidomide for the Treatment of MDS;Myelodysplastic Syndromes;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3